European Medicines Agency's 2025 Report Details New Drug Recommendations

The European Medicines Agency (EMA) has released its 2025 annual report, detailing the recommendation of 104 human medicines for marketing authorization, including 38 new active substances. The report highlights significant regulatory output, advancements in biosimilar policy, and the integration of artificial intelligence into agency operations. It also mentions notable first-in-class treatments authorized for conditions like metabolic dysfunction-associated steatohepatitis and type 1 diabetes.